| Fair Value Measurements |
Fair Value Measurements We use estimates of fair value in applying various accounting standards for our consolidated financial statements.
We categorize our fair value estimates based on a hierarchical framework associated with three levels of price transparency utilized in measuring financial instruments at fair value. For additional information regarding our policies for determining fair value and the hierarchical framework, see Note 2, “Significant Accounting Policies - Fair Value Measurement” in our 2025 Form 10-K.
During the six months ended June 30, 2026, there were no significant transfers of financial instruments between levels or changes in our methodology or assumptions used to value our financial instruments.
The following table summarizes the valuation of our financial instruments that are marked-to-fair value on a recurring basis.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements on a Recurring Basis | | | | June 30, 2026 | | December 31, 2025 | | (Dollars in thousands) | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | | | | | | | | | | | | | | | | | | Assets: | | | | | | | | | | | | | | | | | | Trading investments | | $ | — | | | $ | — | | | $ | 55,938 | | | $ | 55,938 | | | $ | — | | | $ | — | | | $ | 49,250 | | | $ | 49,250 | | | Available-for-sale investments | | — | | | 1,715,212 | | | 1,500 | | | 1,716,712 | | | — | | | 1,756,178 | | | 1,892 | | | 1,758,070 | | | | | | | | | | | | | | | | | | | | Derivative instruments | | — | | | 1 | | | — | | | 1 | | | — | | | — | | | — | | | — | | | Total | | $ | — | | | $ | 1,715,213 | | | $ | 57,438 | | | $ | 1,772,651 | | | $ | — | | | $ | 1,756,178 | | | $ | 51,142 | | | $ | 1,807,320 | | | | | | | | | | | | | | | | | | | | Liabilities: | | | | | | | | | | | | | | | | | | Derivative instruments | | $ | — | | | $ | (3) | | | $ | — | | | $ | (3) | | | $ | — | | | $ | (8) | | | $ | — | | | $ | (8) | | | Total | | $ | — | | | $ | (3) | | | $ | — | | | $ | (3) | | | $ | — | | | $ | (8) | | | $ | — | | | $ | (8) | |
The following table summarizes the change in balance sheet carrying value associated with level 3 financial instruments carried at fair value on a recurring basis.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | | 2026 | | 2025 | | | Investments | | Investments | | (Dollars in thousands) | | Available For Sale - Debt Securities | | Trading - Residual Interests | | Total | | Available For Sale - Debt Securities | | Trading - Residual Interests | | Total | | Balance, beginning of period | | $ | 1,892 | | | $ | 49,250 | | | $ | 51,142 | | | $ | 2,689 | | | $ | 53,262 | | | $ | 55,951 | | | Total gains/(losses): | | | | | | | | | | | | | Included in earnings (or changes in net assets)(1) | | 9 | | | 6,308 | | | 6,317 | | | 11 | | | (3,134) | | | (3,123) | | | Included in other comprehensive income | | (21) | | | — | | | (21) | | | (14) | | | — | | | (14) | | | Settlements | | (380) | | | 380 | | | — | | | (439) | | | (2,974) | | | (3,413) | | | Transfers into level 3 | | — | | | — | | | — | | | — | | | — | | | — | | | Transfers out of level 3 | | — | | | — | | | — | | | — | | | — | | | — | | | Balance, end of period | | $ | 1,500 | | | $ | 55,938 | | | $ | 57,438 | | | $ | 2,247 | | | $ | 47,154 | | | $ | 49,401 | | | | | | | | | | | | | | | | Change in unrealized gains or losses for the period included in other comprehensive income for assets held at the end of the reporting period | | $ | (21) | | | $ | — | | | $ | (21) | | | $ | (14) | | | $ | — | | | $ | (14) | | Change in unrealized gains or losses for the period included in earnings (or changes in net assets) for assets held at the end of the reporting period(2) | | $ | — | | | $ | 6,308 | | | $ | 6,308 | | | $ | — | | | $ | (3,134) | | | $ | (3,134) | |
(1) Included in earnings (or changes in net assets) is comprised of the amounts recorded in the specified line item in the consolidated statements of income:
| | | | | | | | | | | | | | | | | Six Months Ended June 30, | | (Dollars in thousands) | | 2026 | | 2025 | | Interest Income - Investments | | $ | 9 | | | $ | 11 | | | Losses on securities, net | | 6,308 | | | (3,134) | | | Total | | $ | 6,317 | | | $ | (3,123) | |
(2) Recorded in "losses on securities, net" in the consolidated statements of income.
The following table presents the significant unobservable inputs used in the recurring valuations of the level 3 financial instruments detailed above.
| | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 (dollars in thousands) | | Fair Value | | Valuation Technique | | Unobservable Input | | Range (Average) | | Debt Securities | | $ | 1,500 | | | Discounted cash flow | | Constant Prepayment Rate | | 7.0%-10.9% (8.3%) | | | | | | | Probability of default | | 2.9%-17.9% (10.3%) | | Residual Interests | | 55,938 | | | Discounted cash flow | | Constant Prepayment Rate | | 7.0%-10.9% (8.3%) | | | | | | | Probability of default | | 2.9%-17.9% (10.3%) | | Total | | $ | 57,438 | | | | | | | |
The significant inputs detailed in the above table would be expected to have the following impacts to the valuations: •A decrease in constant prepayment rate (“CPR”) would result in a longer weighted average life of the trust, resulting in a decrease to the valuation due to the delay in residual cash flows with the increased term. The opposite is true for an increase in the CPR. •A decrease in the probability of defaults means increased principal receipts, resulting in an increase to the valuation due to the increase in residual cash flow. •Conversely, an increase in the probability of defaults means decreased principal receipts, resulting in a decrease to the valuation due to the decrease in residual cash flow.
The following table summarizes the fair values of our financial assets and liabilities, including derivative financial instruments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | (Dollars in thousands) | | Fair Value | | Carrying Value | | Difference | | Fair Value | | Carrying Value | | Difference | | Earning assets: | | | | | | | | | | | | | | Loans held for investment, net: | | | | | | | | | | | | | | Private Education Loans | | $ | 22,212,200 | | | $ | 19,531,493 | | | $ | 2,680,707 | | | $ | 23,198,134 | | | $ | 20,332,124 | | | $ | 2,866,010 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans held for sale | | 174,632 | | | 172,466 | | | 2,166 | | | 947,078 | | | 933,256 | | | 13,822 | | | Cash and cash equivalents | | 4,588,129 | | | 4,588,129 | | | — | | | 4,241,265 | | | 4,241,265 | | | — | | | Trading investments | | 55,938 | | | 55,938 | | | — | | | 49,250 | | | 49,250 | | | — | | | Available-for-sale investments | | 1,716,712 | | | 1,716,712 | | | — | | | 1,758,070 | | | 1,758,070 | | | — | | | Accrued interest receivable | | 1,701,466 | | | 1,602,311 | | | 99,155 | | | 1,662,640 | | | 1,562,811 | | | 99,829 | | | | | | | | | | | | | | | | Derivative instruments | | 1 | | | 1 | | | — | | | — | | | — | | | — | | | Total earning assets | | $ | 30,449,078 | | | $ | 27,667,050 | | | $ | 2,782,028 | | | $ | 31,856,437 | | | $ | 28,876,776 | | | $ | 2,979,661 | | | Interest-bearing liabilities: | | | | | | | | | | | | | | Money-market and savings accounts | | $ | 10,609,001 | | | $ | 10,631,560 | | | $ | 22,559 | | | $ | 11,187,471 | | | $ | 11,182,022 | | | $ | (5,449) | | | Certificates of deposit | | 9,224,854 | | | 9,262,730 | | | 37,876 | | | 9,830,811 | | | 9,877,945 | | | 47,134 | | | Short-term borrowings | | — | | | — | | | — | | | 489,802 | | | 498,415 | | | 8,613 | | | Long-term borrowings | | 5,785,595 | | | 5,844,116 | | | 58,521 | | | 5,376,909 | | | 5,362,494 | | | (14,415) | | | Accrued interest payable | | 97,204 | | | 97,204 | | | — | | | 97,524 | | | 97,524 | | | — | | | Derivative instruments | | 3 | | | 3 | | | — | | | 8 | | | 8 | | | — | | | Total interest-bearing liabilities | | $ | 25,716,657 | | | $ | 25,835,613 | | | $ | 118,956 | | | $ | 26,982,525 | | | $ | 27,018,408 | | | $ | 35,883 | | | | | | | | | | | | | | | | Excess of net asset fair value over carrying value | | | | | | $ | 2,900,984 | | | | | | | $ | 3,015,544 | |
Please refer to Note 16, “Fair Value Measurements” in our 2025 Form 10-K for a full discussion of the methods and assumptions used to estimate the fair value of each class of financial instruments.
|